9:30 – 9:35 M. Canan Arkan
9:35 – 10:10 Eran Elinav, Weizmann Institute, Israel
Host-microbiome interaction in health and disease
10:10 – 10:45 Michael Zimmermann, European Molecular Biology Laboratory (EMBL), Germany
Identifying gut microbiome contributions to drug metabolism and carcinogen toxicity
10:45 – 11:20 Sergei Grivennikov, Cedars-Sinai Medical Center, USA
Microbial and cytokine determinants of colorectal cancer liver metastasis
11:20 - 11: 50 Coffee break
11:50 – 12:40 Michael Karin, University of California San Diego, USA
The intestinal neuroimmunological network controls the pathogenesis of diet and alcohol induced fatty liver diseases, providing new therapeutic opportunities
12:40 - 14:00 Lunch break
14:00 – 14:30 Katrin Springsgut, Goethe University Frankfurt, Germany
Gender equality in research and in leadership positions
14:30 – 15:05 Georg Zeller, Leiden University Medical Center, Netherlands
Investigating composition, spatial organisation and function of microbial communities associated with colorectal cancer
15:05 – 15:40 Thomas Clavel, RWTH University Aachen, Germany
Diet-microbiome interactions in colorectal cancer
15:40 - 16:00 Coffee break
Continuation
16:00 – 16:35 Falk Hildebrand, Quadram and Earlham Institute, UK
Gut microbial persistence in health and disease
16:35 – 17:10 Silke Matura, Goethe University Frankfurt, Germany
Gut feelings: The role of the gut–brain axis in mental health
19:00 Speakers and Sponsors Dinner
09:30 – 10:05 Nicola Segata, University of Trento, Italy
The microbiome in nutrition and cardiometabolic health
10:05 – 10:40 Achim Kramer, Charité University Hospital Berlin, Germany
Past and future of circadian medicine
10:40 – 11:15 M. Canan Arkan, Georg-Speyer-Haus, Germany
Impact of timed eating on microbial dynamics and treatment outcomes in colorectal cancer
11:15 - 11:45 Coffee break
11:45– 12:20 Christoph Stein-Thöringer, University Hospital Tübingen, Germany
Microbiome and cancer chemotherapy of solid and hematologic malignancies
12:20 – 12:55 Nicola Wilck, Max Delbrück Center, Germany
Host-microbiome interaction in cardiovascular and kidney disease
12:55 - 14:30 Lunch break
14:30 – 15:05 Jens Puschhof, DKFZ, Germany
Modelling cancer-microbe interactions with organoids and organ chips
15:05 – 15:40 Sara Vieira-Silva, Universtiy Medical Center Mainz, Germany
tba
15:40 – 16:15 Lisa Maier, The M3 Research Center, Tübingen, Germany
Drugging the gut microbiome: from unintended side effects to targeted modulation
16:15 - 16:25 M. Canan Arkan
16:40 Museum tour of the historical research site of Paul Ehrlich